322 related articles for article (PubMed ID: 15760766)
21. [Relationship between alpha-synuclein and Parkinson's disease].
Nishioka K; Hattori N
Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
[TBL] [Abstract][Full Text] [Related]
22. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
Lotharius J; Brundin P
Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
[No Abstract] [Full Text] [Related]
24. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
[No Abstract] [Full Text] [Related]
25. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
26. Controlling the mass action of alpha-synuclein in Parkinson's disease.
Kim C; Lee SJ
J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
[TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein in Parkinson's disease: light from two new angles.
Golbe LI; Mouradian MM
Ann Neurol; 2004 Feb; 55(2):153-6. PubMed ID: 14755715
[No Abstract] [Full Text] [Related]
28. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire-Zeiss KA; Short DW; Federoff HJ
Brain Res Mol Brain Res; 2005 Mar; 134(1):18-23. PubMed ID: 15790526
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategies for Parkinson's disease based on data derived from genetic research.
Riess O; Berg D; Krüger R; Schulz JB
J Neurol; 2003 Feb; 250 Suppl 1():I3-10. PubMed ID: 12761628
[TBL] [Abstract][Full Text] [Related]
30. [Study on exons 3 and 4 of alpha-synuclein gene in Chinese familial Parkinson disease patients].
Chen X; Liu YT; Li JR; Chen L; Xu YM; Pan YH; Meng XH; Xing SH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):536-8. PubMed ID: 14669226
[TBL] [Abstract][Full Text] [Related]
31. [alpha-Synuclein and familial Parkinson's disease].
Iwatsubo T
No To Shinkei; 1999 Jun; 51(6):481-6. PubMed ID: 10423749
[No Abstract] [Full Text] [Related]
32. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
Mellick GD; Maraganore DM; Silburn PA
Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
[TBL] [Abstract][Full Text] [Related]
33. Experimental models of Parkinson's disease.
Beal MF
Nat Rev Neurosci; 2001 May; 2(5):325-34. PubMed ID: 11331916
[TBL] [Abstract][Full Text] [Related]
34. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.
Ibáñez P; Bonnet AM; Débarges B; Lohmann E; Tison F; Pollak P; Agid Y; Dürr A; Brice A
Lancet; 2004 Sep 25-Oct 1; 364(9440):1169-71. PubMed ID: 15451225
[TBL] [Abstract][Full Text] [Related]
35. Alpha-synuclein dysfunction in Lewy body diseases.
Tofaris GK; Spillantini MG
Mov Disord; 2005 Aug; 20 Suppl 12():S37-44. PubMed ID: 16092089
[TBL] [Abstract][Full Text] [Related]
36. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.
Chartier-Harlin MC; Kachergus J; Roumier C; Mouroux V; Douay X; Lincoln S; Levecque C; Larvor L; Andrieux J; Hulihan M; Waucquier N; Defebvre L; Amouyel P; Farrer M; Destée A
Lancet; 2004 Sep 25-Oct 1; 364(9440):1167-9. PubMed ID: 15451224
[TBL] [Abstract][Full Text] [Related]
37. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
[TBL] [Abstract][Full Text] [Related]
38. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.
Volles MJ; Lansbury PT
Biochemistry; 2003 Jul; 42(26):7871-8. PubMed ID: 12834338
[TBL] [Abstract][Full Text] [Related]
39. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease.
Michell AW; Luheshi LM; Barker RA
Neurosci Lett; 2005 Jun; 381(3):294-8. PubMed ID: 15896487
[TBL] [Abstract][Full Text] [Related]
40. Targeting alpha-synuclein in Parkinson's disease.
Kapurniotu A
Chem Biol; 2004 Nov; 11(11):1476-8. PubMed ID: 15555995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
